Senior insider sale
President & CEO at ETON PHARMACEUTICALS, INC. — senior position signals high conviction
$3.89M
120K shares
What this filing means
BRYNJELSEN SEAN plans to sell 120K shares of ETON PHARMACEUTICALS, INC. valued at approximately $3.89M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/28/2026ACC: 0001949846-26-000326
DirectorOfficer· President & CEO
Since Nov 2018
120K
Shares to sell
$3.89M
Approx. market value
220K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
Open Market Purchase
Cash
8/21/2021
10KOpen Market Purchase
Cash
6/3/2021
5KOpen Market Purchase
Cash
8/13/2019
5KFounder Shares
Grant
5/17/2017
200KTotal acquired220K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/21/2021 | Open Market Purchase Cash | 10K | — |
6/3/2021 | Open Market Purchase Cash | 5K | — |
8/13/2019 | Open Market Purchase Cash | 5K | — |
5/17/2017 | Founder Shares Grant | 200K | — |
| Total | 220K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
120K
Market value
$3.89M
5/28/2026
Total
Units
120K
Value
$3.89M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/28/2026 | 120K | $3.89M | NASDAQ | Planned |
| Total | 120K | $3.89M | ||